Stay updated on Idasanutlin Combo Therapy in AML Clinical Trial
Sign up to get notified when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.

Latest updates to the Idasanutlin Combo Therapy in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now reflects a new revision version (v3.6.5), indicating a platform update rather than a change to the study information.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small platform/template update; no substantive study information appears to have changed.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This appears to be a minor site update and does not change the study content or results.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now indicates that recruitment has ended and adds new help sections for reading the study record and joining the study, while reorganizing the Intervention/Treatment heading to reflect current content.SummaryDifference0.4%

- Check81 days agoChange DetectedThe page shows an updated Revision: v3.5.5 replacing the previous v3.5.4, indicating a metadata or software update to the page.SummaryDifference0.0%

Stay in the know with updates to Idasanutlin Combo Therapy in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Idasanutlin Combo Therapy in AML Clinical Trial page.